Concepedia

Publication | Open Access

Osimertinib vs comparator EGFR-TKI as first-line treatment for EGFRm advanced NSCLC (FLAURA): Final overall survival analysis

DOIFull Paper Access

68

Citations

0

References

2019

Year

Sendhilnathan Ramalingam, J.E. Gray, Yuichiro Ohe, Byoung Chul Cho, Johan Vansteenkiste, C. Zhou, Thanyanan Reungwetwattana, Ying Cheng, B. Chewaskulyong, Riyaz Shah,
Annals of Oncology

No additional data available for this publication yet. Check back later!